GlaxoSmithKline Eyeing Bolt-On Acquisitions In Consumer Health

GlaxoSmithKline is planning to move aggressively beyond its core prescription drug business with possible bolt-on purchases in consumer health among other categories, CEO Andrew Witty told investors at a recent Goldman Sachs conference in New York